由HBeAg阴性患者分离体对HBsAg释放和抗增殖/抗氧化细胞调节的受损反映了进化过程
Michael Basic1,2, Keerthihan Thiyagarajah1,2, Mirco Glitscher2
1Department of Gastroenterology and Hepatology, University Hospital Frankfurt, Frankfurt, Germany.
概括
肝炎Be抗原 (HBeAg) 阴性第3期基因组显示HBsAg的产生和释放较低,抗氧化反应增强,激酶活性降低,有助于减少增殖状态和潜在降低肝癌风险.
科学领域:
- 病毒学 病毒学
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
背景情况:
- 肝炎Be抗原 (HBeAg) 阴性第3期感染通常呈现出最小的肝炎和无纤维化.
- 在HBeAg阴性第3期感染中,这种良性表型的分子基础在很大程度上是未知的.
研究的目的:
- 为了研究 HBeAg 阴性 3 期乙型肝炎病毒 (HBV) 感染的良性表型背后的分子机制.
- 为了比较HBeAg阴性3期HBV基因组与HBeAg阳性对应物的分子特征.
主要方法:
- 从第3阶段的基因型A,B和D HBeAg阴性患者分离物 (核心前突变G1896A) 的分析.
- 与HBeAg阳性救援突变动物和野生类型参考基因组的比较.
- 评估病毒复制,形态发生,感染性和对Nrf2/ARE依赖基因表达和细胞基因组的影响.
主要成果:
- HBeAg阴性分离物表现出较低的细胞内和细胞外B型肝炎表面抗原 (HBsAg) 水平,并增加了内质网膜中的HBsAg保留.
- 与参考基因组相比,在患者隔离物中观察到更高的Nrf2/ARE依赖基因表达,无论HBeAg表达如何.
- 基因组分析显示,在所有患者隔离物中,激酶调节增殖途径的活性下降.
结论:
- HBeAg 阴性 3 期基因组具有独特的分子特征,包括减少 HBsAg 合成/释放,增强氧化应激保护和抑制激酶活性.
- 这些分子变化促进了抗增殖状态,可能降低肝细胞癌的风险.
- 观察到的表型可能是多因素过程和自然选择的结果,不仅仅归因于HBeAg损失或特定常见突变.
相关概念视频
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...